The company‘s biomolecular models can integrate outputs from quantum computers to accelerate CPU or GPU-based methods routinely used in structure-based drug discovery, such as molecular similarity and conformational search. (nextbigfuture.com)
By visiting our site, you agree to our privacy policy regarding cookies, tracking statistics, etc.